Pioneering Excellence in Biosciences
Dr. Vishal G. Warke, a qualified MBBS and PhD holder, leads as the Director of Cell Biology and Hydroponics at HiMedia Laboratories Pvt. Ltd, which is a globally trusted brand with a presence in over 150 countries. HiMedia transformed from its modest origins in 1974 as a small microbiology media manufacturer in Mumbai into a leading global provider of advanced bioscience solutions & products. The company offers more than 30,000 SKUs which empowers the healthcare, pharmaceutical, food and beverage, cosmetic, agriculture, and biopharma sectors.
“DR. VISHAL EMPOWERS BIOTECH STARTUPS BY OFFERING MENTORSHIP & ACCESS TO HIMEDIA’S INFRASTRUCTURE. HIS COLLABORATIVE APPROACH BRIDGES THE GAP BETWEEN ACADEMIA & INDUSTRIES, ACCELERATING INNOVATION AND BUILDING STRONG PARTNERSHIPS WITH UNIVERSITIES, RESEARCH INSTITUTES, AND EARLY-STAGE COMPANIES”
Dr. Vishal holds an MBBS degree from the University of Mumbai and a PhD in Cell Biology and Molecular Genetics from the University of Maryland, USA. He received the prestigious Medical Research Fellowship from “The Walter Reed Army Institute of Research.” His academic and research background have shaped his ability to lead product development in key areas such as Chemically Defined Serum Free Media (CDSFM) for Biopharma, Media for cultivated meat, Bioinks for 3D Bioprinting, Lymphocyte Separation Media, and Viral Transport Media.
TRANSFORMATION OF HIMEDIA LABORATORIES
HiMedia was established in 1974 by his parents Dr. Gangadhar M. Warke and Mrs. Saroj G. Warke along with his uncle Mr. Vishnu M. Warke, with a vision of providing affordable, high-quality culture media to researchers across India. Dr. Vishal G. Warke and his wife Dr. Priti V. Warke (Director of Cell Culture & Head of Regulatory Affairs, HiMedia) have been instrumental in broadening the company’s scope and enhancing its global presence. Under their guidance, HiMedia has expanded beyond its earlier domain, by developing a diverse portfolio in cell biology, molecular biology, plant tissue culture, biochemicals, laboratory consumables, and hydroponics solutions. This diversification reflects HiMedia’s keen grasp of evolving scientific needs and commitment to making quality products and solutions accessible to the wider scientific community.
INNOVATION THROUGH RESEARCH
Dr. Vishal emphasizes the pivotal role of rigorous research and development (R&D) in sustaining HiMedia’s legacy of innovation. Thus, he invests 16% of the company’s profits into R&D to support innovative projects. A notable example of such investment is the acquisition of the Orbitrap Fusion Tribrid Mass Spectrometer, which has significantly strengthened HiMedia’s expertise in metabolomics, proteomics, and peptidomics. This high-resolution technology helps in accurate identification and quantification of biological compounds, thus contributing to advancements in key areas like proteomics, metabolomics, and biomarker research. HiMedia, under Dr. Vishal’s guidance, has also made significant strides in the development of bioscaffolds for 3D bioprinting, enabling possibilities like autologous organ transplantation. Under the stewardship of Dr. Vishal & Dr. Priti, the company has also pioneered the development of animal-free media tailored for cultivated meat production, which offers specialized formulations for CHO cells as well as general cell culture applications. These advanced media are meticulously designed to promote robust cell growth and differentiation without relying on conventional animal serum, thereby reducing production costs and addressing the ethical and sustainability concerns associated with conventional serum-based methods. These initiatives collectively align with global objectives to lower carbon emissions and advance ethical food production.
CAREER MILESTONES
Dr. Vishal’s remarkable achievement is steering HiMedia into the cultivated meat sector. He has led the development as well as large-scale production of cost-effective, serum-free media formulations which are essential for producing high quality meat without the use of animals. This initiative fosters sustainable food production while advancing innovation, thus establishing HiMedia as one of India’s leading bioscience enterprises with a significant contribution to this rapidly expanding global industry.
In 2020, at the peak of the COVID-19 pandemic, Dr. Vishal & Dr. Priti spearheaded a rapid and large-scale production effort to meet the Indian government’s urgent demand for Viral Transport Medium (VTM) kits. Under their guidance, HiMedia ramped up production of VTM from 0.5 million kits per year to a staggering 1 million kits per day. This swift response played a vital role in strengthening India’s COVID-19 diagnostic efforts and signified HiMedia’s reliability in times of national emergency.
Prior to that, Dr. Priti led the rapid development of HiViral–VTM within two months during the 2009 H1N1 epidemic, a product later crucial for COVID-19 testing nationwide. Further, Dr. Vishal established a cGMP-certified facility in Nashik, thus ensuring HiMedia’s operations adhere to the highest global regulatory standards. He further advanced the company’s international footprint by setting up offices and warehouses in the USA and Germany, significantly improving product accessibility and customer support worldwide.
BACKING BIOTECH INNOVATION
As a champion of innovation, Dr. Vishal supports numerous biotech startups by providing both mentorship and access to HiMedia’s infrastructure. His collaboration with early-stage companies helps bring innovative ideas to market quickly. His commitment to multidisciplinary collaboration has enabled him to build strong partnerships with various national and international universities, research institutions, and industrial leaders.
SCOOPING UP ACCOLADES
Dr. Vishal’s steadfast commitment has brought him as well as HiMedia numerous prestigious accolades. In 2023, he received the “Best Innovator for COVID-19 Solutions” award at the BioSpectrum India Excellence Awards and also won the “BIRAC Innovator Award” in 2020. HiMedia was named the ‘Best Company of the Year 2018’ in the ‘Pride of Maharashtra’ awards by the Maharashtra Industrial and Economic Development Association. HiMedia was honored at the Maharashtra State Level in the Biosciences category and was invited to the ‘Make in India Week’ event held in Mumbai in the year 2016. His work in areas like biosimilar media, T-cell receptors, and systemic lupus erythematosus is also recognized internationally, with over 20 research papers published in high impact journals.
GIVING BACK TO SOCIETY
Under Dr. Vishal’s guidance, HiMedia has partnered with the Indian Institute of Technology, Bombay (IIT-B) to establish the Wadhwani Research Centre for Bioengineering (WRCB)–HiMedia Bio-Innovation Centre, a state-of-the-art facility dedicated to advancing research and entrepreneurship in healthcare and life sciences. This collaboration has strengthened initiatives such as patent facilitation and deep-tech entrepreneurship fellowships, with a strategic focus on diagnostics, therapeutics, 3D cell culture, cancer biology, and synthetic biology. He also led HiMedia’s donation towards establishing a Regenerative Medicine Research Centre at Sir J.J Hospital, Mumbai, in developing stem cell therapies for eye care.
